The latest GP contract update for 2026/27 signals a continued shift in how primary care is delivered in England, with implications that will resonate across care settings. It introduces a series of targeted changes aimed at improving access, strengthening accountability and stabilising general practice. The changes reinforce a direction of travel already underway following the 10-Year Plan, including greater integration, expanded multidisciplinary teams and increasing responsibility for pharmacy professionals across care settings.

The update to the contract builds on the Long Term Plan with a focus on improving access, expanding digital triage and stabilising general practice capacity. Central to this is the continued evolution of the Additional Roles Reimbursement Scheme (ARRS), which remains a key mechanism for embedding pharmacists within primary care networks (PCNs).

For pharmacy, ARRS expansion continues to formalise the role of pharmacists in delivering structured medication reviews, managing long-term conditions and supporting prescribing safety. However, it also brings increased expectations. As GP workload pressures persist, pharmacy professionals are increasingly expected to absorb medicines-related activity, including elements of prescribing responsibility and ongoing patient management.

Access requirements are also tightening. The contract mandates that patients identified as clinically urgent must be managed on the same day, and practices must not ask patients to call back another day. This is likely to increase demand on triage systems and accelerate the use of digital access and care navigation, with pharmacy professionals playing a growing role in managing medicines-related presentations.

This shift is already being felt across the system. In primary care, PCN and practice-based pharmacy professionals are taking on more direct patient-facing roles, supported by digital triage models that route patients toward the most appropriate clinician. The contract’s emphasis on improving access, including same-day demand management, is likely to further accelerate this trend.

In secondary care, the implications are equally significant. As more care is delivered closer to home, hospital pharmacy teams are seeing growing demand for shared care arrangements, discharge medicines optimisation and ongoing prescribing support. The interface between care settings remains a critical pressure point, particularly where responsibilities for monitoring and prescribing are not consistently defined or commissioned.

Digital transformation is a key enabler within the contract. NHS England highlights the continued development of digital access routes and improved use of data to support population health management. For pharmacy leaders, this presents both opportunity and risk. Interoperability between primary and secondary care systems remains variable, and without alignment, so there is potential for increased fragmentation in medicines optimisation and safety processes.

Funding and commissioning also sit at the heart of the changes. While the contract includes investment to support general practice, system leaders, particularly medicines optimisation leads, will need to ensure that resources are aligned to support expanded pharmacy roles and avoid cost-shifting between sectors.

Further changes clarify PCN responsibilities for vaccinations, cancer screening, continuity of care and neighbourhood working, reinforcing expectations around integrated delivery. At the same time, new requirements to strengthen patient choice and improve communication with community pharmacy, alongside services such as Pharmacy First, signal a more distributed primary care model, with pharmacy playing a central access role.

Updates to Quality and Outcomes Framework (QOF) indicators, including those related to obesity and structured weight management, also reinforce the growing importance of long-term condition management within primary care pharmacy roles.

For delegates attending Clinical Pharmacy Congress, the GP contract indicates that it is not just a primary care policy, but a system-wide driver of change. Pharmacy will be central to delivering its ambitions, but success will depend on how effectively leaders navigate integration, workforce development and shared accountability across organisational boundaries.